Effect of Silymarin on Expression of micro-RNA-21 and Matrix Metalloproteinase (MMP) 2 and 9 and Tissue Inhibitors of Matrix Metalloproteinase (TIMP) 1 and 2 in Hepatocellular Carcinoma Cell Line (HepG2).
{"title":"Effect of Silymarin on Expression of micro-RNA-21 and Matrix Metalloproteinase (MMP) 2 and 9 and Tissue Inhibitors of Matrix Metalloproteinase (TIMP) 1 and 2 in Hepatocellular Carcinoma Cell Line (HepG2).","authors":"Maryam Hormozi, Meysam Moulaee, Mahdi Alaee, Nasim Beigi Boroujeni, Mandana Beigi Boroujeni","doi":"10.47176/mjiri.38.78","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Silymarin is a flavonolignan that has various medicinal properties such as liver protection, antioxidant, anti-inflammatory, anti-cancer and heart protection activities. The aim of this study was to investigate the effect of silymarin on the expression level of <i>mir-21</i>, matrix metalloproteinase(<i>MMP</i>), and their tissue inhibitors (<i>TIMPs</i>) in liver cancer HepG2 cell line.</p><p><strong>Methods: </strong>An <i>in-vitro</i> experimental study was conducted on the human HepG2 cells prepared from Pasteur Institute, Tehran, Iran. Four concentrations of 0 (control), 50, 100, and 150 µM of silymarin were considered as the study groups according to the MTT assay. Gene expression study was performed using real-time PCR. The studied genes were <i>mir-21</i>, <i>MMP-2</i>, <i>MMP-9</i>, <i>TIMP-1</i> and <i>TIMP-2</i>. In addition, some apoptosis-related genes including <i>BAX</i>, <i>BCL2</i> and <i>Caspase3</i> (<i>CAS3</i>) were investigated. <i>GAPDH</i> was used as an internal control. Relative expression was calculated by REST program using t-test on the logarithm of expression considering a significance level of 0.05.</p><p><strong>Results: </strong>The significant up-regulations consisted of <i>TIMP</i> genes for doses 100 µM and 150 µM, and the apoptosis activating genes <i>CAS3</i> and <i>BAX</i> (<i>P</i> < 0.05). The significant down-regulations consisted of <i>MMP-9</i> in all concentrations, <i>MMP-</i>2 in concentration 100 µM, and the apoptosis inhibitory gene <i>BCL2</i> in concentrations 50 µM and 100 µM (<i>P</i> < 0.05). In addition, <i>mir-21</i> as an oncogenic micro-RNA showed significant down-regulation for all doses (<i>P</i> < 0.05). All the comparisons were with the control group.</p><p><strong>Conclusion: </strong>The present study showed that silymarin could affect the HepG2 cell line at the gene expression level <i>via</i> increasing apoptosis and changing the expression of <i>MMP-2</i>, <i>MMP-9</i>, <i>TIMP-1</i>, <i>TIMP-2</i> and <i>mir-21</i>. These findings were in line with each other and in favor of suppression of tumoral activity in this cell line.</p>","PeriodicalId":18361,"journal":{"name":"Medical Journal of the Islamic Republic of Iran","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480674/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of the Islamic Republic of Iran","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47176/mjiri.38.78","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Silymarin is a flavonolignan that has various medicinal properties such as liver protection, antioxidant, anti-inflammatory, anti-cancer and heart protection activities. The aim of this study was to investigate the effect of silymarin on the expression level of mir-21, matrix metalloproteinase(MMP), and their tissue inhibitors (TIMPs) in liver cancer HepG2 cell line.
Methods: An in-vitro experimental study was conducted on the human HepG2 cells prepared from Pasteur Institute, Tehran, Iran. Four concentrations of 0 (control), 50, 100, and 150 µM of silymarin were considered as the study groups according to the MTT assay. Gene expression study was performed using real-time PCR. The studied genes were mir-21, MMP-2, MMP-9, TIMP-1 and TIMP-2. In addition, some apoptosis-related genes including BAX, BCL2 and Caspase3 (CAS3) were investigated. GAPDH was used as an internal control. Relative expression was calculated by REST program using t-test on the logarithm of expression considering a significance level of 0.05.
Results: The significant up-regulations consisted of TIMP genes for doses 100 µM and 150 µM, and the apoptosis activating genes CAS3 and BAX (P < 0.05). The significant down-regulations consisted of MMP-9 in all concentrations, MMP-2 in concentration 100 µM, and the apoptosis inhibitory gene BCL2 in concentrations 50 µM and 100 µM (P < 0.05). In addition, mir-21 as an oncogenic micro-RNA showed significant down-regulation for all doses (P < 0.05). All the comparisons were with the control group.
Conclusion: The present study showed that silymarin could affect the HepG2 cell line at the gene expression level via increasing apoptosis and changing the expression of MMP-2, MMP-9, TIMP-1, TIMP-2 and mir-21. These findings were in line with each other and in favor of suppression of tumoral activity in this cell line.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
